Epilepsy Drugs in Nigeria

Epilepsy is one of the most treatable neurological conditions there is and one of the worst treated in Nigeria — the World Health Organization puts the treatment gap across sub-Saharan Africa at around 75%, meaning three in four people who could be seizure-free on a cheap daily tablet are not taking one. The medicines here do the same job by different routes: carbamazepine and sodium valproate are the long-established workhorses, both on WHO's essential medicines list, both widely registered and affordable. Levetiracetam is the newer option — fewer interactions, safer in pregnancy, considerably more expensive, and held by only three companies in the NAFDAC register.

Two things decide whether epilepsy treatment works, and neither is the choice of drug. The first is never stopping suddenly: abrupt withdrawal of any antiepileptic can trigger seizures worse than the original ones, so a supply gap is a reason to call your doctor the same day, not to wait and see. The second is pregnancy planning. Sodium valproate causes birth defects in roughly one in ten exposed pregnancies and developmental problems in three to four in ten — the highest risk of any common antiepileptic — and carbamazepine both carries its own risk and stops hormonal contraception working. Any girl or woman of childbearing age on epilepsy medicine deserves that conversation before it becomes urgent, not after.